<code id='01D5EBD103'></code><style id='01D5EBD103'></style>
    • <acronym id='01D5EBD103'></acronym>
      <center id='01D5EBD103'><center id='01D5EBD103'><tfoot id='01D5EBD103'></tfoot></center><abbr id='01D5EBD103'><dir id='01D5EBD103'><tfoot id='01D5EBD103'></tfoot><noframes id='01D5EBD103'>

    • <optgroup id='01D5EBD103'><strike id='01D5EBD103'><sup id='01D5EBD103'></sup></strike><code id='01D5EBD103'></code></optgroup>
        1. <b id='01D5EBD103'><label id='01D5EBD103'><select id='01D5EBD103'><dt id='01D5EBD103'><span id='01D5EBD103'></span></dt></select></label></b><u id='01D5EBD103'></u>
          <i id='01D5EBD103'><strike id='01D5EBD103'><tt id='01D5EBD103'><pre id='01D5EBD103'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          Wikipedia

          author:focus    - browse:5
          President Joe Biden speaks and gestures at a podium outdoor
          In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors. MANDEL NGAN/AFP via Getty Images

          WASHINGTON — The Biden administration announced Tuesday that it’s raising taxes on a range of imported products from China, including syringes, needles, and surgical gloves. 

          Pitched as a plan to support American workers, the tariffs are meant to protect domestic manufacturers from China’s “unfair trade practices” and “artificially low-priced exports.” In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors. 

          advertisement

          Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

          The inclusion of syringes comes after the Food and Drug Administration’s repeated warnings to U.S. medical providers about quality issues with plastic syringes from China. The agency first alerted consumers in November 2023 about leaks and breaks associated with Chinese syringes. In March, the FDA called attention to three warning letters it sent to firms in China for selling syringes that had not received FDA clearance. It has since sent a warning letter to Cardinal Health.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia